Related Experiment Video
Updated: Aug 16, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Primary orbital squamous cell carcinoma treated with definitive radiotherapy
Sapna Krishnamurthy1, Imtiaz Ahmed1
1Department of Radiation Oncology, JNMC and KLES Dr. Prabhakar Kore Hospital and MRC KAHER, Belgaum, Karnataka, India.
Abstract:
Squamous cell carcinoma (SCC) arising from the orbit is a rare entity. Only a dozen of such cases are reported in the literature. Owing to its rarity, standard treatment is not defined, but most are treated with surgery. Herewith, we report the case of primary orbital SCC, in a 56-year-old female treated with radiotherapy (RT) alone, who presented with features of left-sided painful blind eye of 4 months' duration. Clinical and imaging studies pointed to no other possible primary malignancy elsewhere in the body, and a final diagnosis of locally advanced primary orbital SCC was made. The patient was treated with intensity-modulated RT, to a total dose of 66Gy in 33 fractions and completed the treatment with good pain relief. Response assessment imaging showed a complete response to treatment. At 2-year follow-up, the patient is alive, without disease and with normal vision in the unaffected eye. To conclude, primary orbital SCC is rare and can be treated successfully with RT.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...